Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03

Karen Hager(Medicago (Canada)), Nathalie Landry(Medicago (Canada)), Marc‐André D’Aoust(Medicago (Canada)), Junya Namba(Medicago (Canada)), Emmy Pahmer(Medicago (Canada)), Manon Couture(Medicago (Canada)), Annie Séguin(Medicago (Canada)), Stéphane Pillet(Medicago (Canada)), Iohann Boulay(Institut National de la Recherche Scientifique), Julie Parent(Medicago (Canada)), Marguerite Koutsoukos(GlaxoSmithKline (Belgium)), Julia Jiang-Wright(Medicago (Canada)), А. И. Макарков(McGill University Health Centre), Gretchen Heizer(Duke University), Thomas Breuer(Economie Publique), Kapil Bhutada(Medicago (Canada)), Fernando Riera(Universidad Nacional de Córdoba), Luan T. Tran(Medicago (Canada)), Pooja Saxena(Medicago (Canada)), Maria Angeles Ceregido(GlaxoSmithKline (Belgium)), Christine E. Jones(University Hospital Southampton NHS Foundation Trust), François Roman(GlaxoSmithKline (Belgium)), Priscila Geller Wolff, Sophie Lapointe(Medicago (Canada)), Garry Wallace(Dawson College), Judith Atkins(Medicago (Canada)), Ricardo Sobhie Diaz(Rockefeller University), Lawrence H. Moulton(Johns Hopkins University), Hessam Aazami(HOPE Clinic), Sonia Trépanier(Medicago (Canada)), Conrado J. Llapur(National University of Tucumán), Philipe Gobeil(Medicago (Canada)), Jiwanjeet K. Dhaliwall(Medicago (Canada)), Eduardo Vasconcellos(Hospital de Clínicas), Yosuke Kimura(Medicago (Canada)), Asif Mahmood(Medicago (Canada)), Gonzalo Pérez Marc(Argerich Hospital), Aurélien Lorin(Medicago (Canada)), Fernando P. Polack(Infant Foundation), Nathalie Charland(Medicago (Canada))
medRxiv
January 26, 2022
Cited by 7


Related Papers